Medical devices and pharmaceuticals continue to gain momentum, entering new markets around the world and providing technological advances in disease management in a variety of conditions. However, such interventions can also carry predictable and unpredictable risks and, under certain circumstances, can have immediate, life-threatening consequences. Regulators assessing market approval for new products should weigh the […]
